The promise of oral IL ‐23 blockade: One‐year control of high‐impact site psoriasis
Journal of the European Academy of Dermatology and Venereology · 2026-09 · 40 (9) · 1443-1444
DOI: 10.1111/jdv.70593 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 25.08.2026. Verfasst von Fatma Jendoubi. Beteiligte Einrichtung: Dermatology Private Practice, Toulouse, France. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Dermatology Private Practice, Toulouse, France.
ORCID-Profile: Fatma Jendoubi
Zitieren
APA
Jendoubi, F. (2026). The promise of oral IL ‐23 blockade: One‐year control of high‐impact site psoriasis. Journal of the European Academy of Dermatology and Venereology, 40(9), 1443-1444. https://doi.org/10.1111/jdv.70593
Vancouver
Jendoubi F. The promise of oral IL ‐23 blockade: One‐year control of high‐impact site psoriasis. Journal of the European Academy of Dermatology and Venereology. 2026;40(9):1443-1444. doi:10.1111/jdv.70593
BibTeX
@article{Jendoubi2026,
author = {Jendoubi, Fatma},
title = {The promise of oral IL ‐23 blockade: One‐year control of high‐impact site psoriasis},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2026},
volume = {40},
number = {9},
pages = {1443--1444},
doi = {10.1111/jdv.70593}
}
EUVIMED